REFERENCES
- James D. Anti-D prophylaxis in 1997: The Edinburgh Consensus Statement. ArchDis Child Fetal Neona-talEd. 1998;78:F161- F165.
- Berger HM, LindemanJHN, van Zoeren-Grobben D, Houdkamp E, Schrijver J, Kanhai HH. Iron overload, free radical damage and rhesus hemolytic disease. Lancet. 1990;335:933-936.
- Nasrat HA, Nicolini U, Nicolaidis P, Letsky EA, Gau G, Rodeck CH. The effect of intrauterine intravascular blood transfusion on iron metabolism in fetuses with Rh alloimmunisation. Obstet Gynecol 1991;77:558-562.
- Fleming RE. Cord serum ferritin levels, fetal iron status and neurodevelopmental outcomes: corre-lations and confounding variables. JPediatr. 2002;140:145-148.
- Georgieff MK, Wewerka SW, Nelson CA, deRegnier RA. Iron status at 9 months of infants with low iron stores at birth. JPediatr. 2002;141:405-409.
- Carpani G, Marini F, Ghisoni L, Buscaglia M, Sinigaglia E, Moroni G. Red cell and plasma ferritin in a group of normal fetuses at different ages of gestation. EurJHematol. 1992;49:260-262.
- Chockalingam UM, Murphy E, OphovenJC, Weisdorf SA, Georgieff MK. Cord transferrin and ferritin values in newborn infants at risk for prenatal uteroplacental insufficiency and chronic hypoxia. JPediatr. 1987;111:283-286.
- Carpani G, Marini F, Ghisoni L, Buscaglia M, Sinigaglia E, Moroni G. Red cell and plasma ferritin in a group of normal fetuses at different ages of gestation. EurJHematol. 1992;49:260-262.
- Georgieff MK, Wewerka SW, Nelson CA, deRegnier R-A. Iron status at 9 months of infants with low iron stores at birth. JPediatr. 2002;141:405-409.
- Thorp JA, O’Connor T, Callenbach J, et al. Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease. Am J Obstet Gynecol 1991;165:79-81.
- Ovali F, Samanci N, Dagoglu T. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study). PediatrRes. 1996;39:831-834.